ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/09/01 | 1,658 | 1,663 | 1,629 | 1,658 | -2 | -0.1% | 1,033,500 |
| 2023/08/31 | 1,694 | 1,708 | 1,658 | 1,660 | -39 | -2.3% | 1,445,700 |
| 2023/08/30 | 1,718 | 1,727 | 1,690 | 1,699 | -16 | -0.9% | 981,000 |
| 2023/08/29 | 1,682 | 1,728 | 1,678 | 1,715 | +68 | +4.1% | 1,725,700 |
| 2023/08/28 | 1,643 | 1,678 | 1,637 | 1,647 | +10 | +0.6% | 991,100 |
| 2023/08/25 | 1,661 | 1,664 | 1,628 | 1,637 | -42 | -2.5% | 1,167,700 |
| 2023/08/24 | 1,706 | 1,712 | 1,674 | 1,679 | +3 | +0.2% | 759,100 |
| 2023/08/23 | 1,691 | 1,706 | 1,675 | 1,676 | -31 | -1.8% | 960,000 |
| 2023/08/22 | 1,676 | 1,729 | 1,670 | 1,707 | +31 | +1.8% | 1,209,700 |
| 2023/08/21 | 1,655 | 1,725 | 1,653 | 1,676 | -8 | -0.5% | 1,327,000 |
| 2023/08/18 | 1,678 | 1,705 | 1,661 | 1,684 | +35 | +2.1% | 1,764,200 |
| 2023/08/17 | 1,629 | 1,649 | 1,605 | 1,649 | -20 | -1.2% | 1,766,900 |
| 2023/08/16 | 1,695 | 1,708 | 1,628 | 1,669 | -31 | -1.8% | 2,135,900 |
| 2023/08/15 | 1,741 | 1,743 | 1,692 | 1,700 | -33 | -1.9% | 1,447,300 |
| 2023/08/14 | 1,732 | 1,741 | 1,692 | 1,733 | +11 | +0.6% | 1,219,500 |
| 2023/08/10 | 1,730 | 1,749 | 1,697 | 1,722 | -9 | -0.5% | 1,464,700 |
| 2023/08/09 | 1,734 | 1,745 | 1,696 | 1,731 | +9 | +0.5% | 1,564,400 |
| 2023/08/08 | 1,780 | 1,791 | 1,712 | 1,722 | -58 | -3.3% | 2,664,800 |
| 2023/08/07 | 1,755 | 1,783 | 1,668 | 1,780 | +27 | +1.5% | 3,994,500 |
| 2023/08/04 | 1,758 | 1,773 | 1,741 | 1,753 | -8 | -0.5% | 1,545,700 |
| 2023/08/03 | 1,780 | 1,834 | 1,739 | 1,761 | -48 | -2.7% | 3,070,800 |
| 2023/08/02 | 1,845 | 1,853 | 1,790 | 1,809 | -37 | -2% | 2,380,800 |
| 2023/08/01 | 1,820 | 1,877 | 1,808 | 1,846 | +32 | +1.8% | 4,237,400 |
| 2023/07/31 | 1,859 | 1,886 | 1,814 | 1,814 | -14 | -0.8% | 5,125,400 |
| 2023/07/28 | 1,723 | 1,838 | 1,721 | 1,828 | +53 | +3% | 7,058,800 |
| 2023/07/27 | 1,862 | 1,865 | 1,753 | 1,775 | -119 | -6.3% | 10,504,700 |
| 2023/07/26 | 1,794 | 1,896 | 1,794 | 1,894 | +100 | +5.6% | 14,301,800 |
| 2023/07/25 | 1,771 | 1,839 | 1,707 | 1,794 | +24 | +1.4% | 17,009,600 |
| 2023/07/24 | 1,575 | 1,798 | 1,542 | 1,770 | +197 | +12.5% | 22,283,900 |
| 2023/07/21 | 1,508 | 1,660 | 1,491 | 1,573 | +157 | +11.1% | 22,828,900 |
| 2023/07/20 | 1,449 | 1,456 | 1,416 | 1,416 | -67 | -4.5% | 2,486,600 |
| 2023/07/19 | 1,444 | 1,503 | 1,444 | 1,483 | +53 | +3.7% | 2,879,700 |
| 2023/07/18 | 1,415 | 1,430 | 1,392 | 1,430 | +10 | +0.7% | 1,987,900 |
| 2023/07/14 | 1,436 | 1,453 | 1,404 | 1,420 | -27 | -1.9% | 1,773,900 |
| 2023/07/13 | 1,429 | 1,447 | 1,371 | 1,447 | +33 | +2.3% | 3,858,600 |
| 2023/07/12 | 1,525 | 1,536 | 1,400 | 1,414 | -112 | -7.3% | 5,008,900 |
| 2023/07/11 | 1,530 | 1,565 | 1,520 | 1,526 | +10 | +0.7% | 2,530,900 |
| 2023/07/10 | 1,491 | 1,550 | 1,491 | 1,516 | +10 | +0.7% | 3,331,500 |
| 2023/07/07 | 1,537 | 1,566 | 1,486 | 1,506 | -49 | -3.2% | 4,742,700 |
| 2023/07/06 | 1,568 | 1,624 | 1,554 | 1,555 | -26 | -1.6% | 5,366,400 |
| 2023/07/05 | 1,568 | 1,607 | 1,541 | 1,581 | +2 | +0.1% | 5,520,500 |
| 2023/07/04 | 1,524 | 1,627 | 1,515 | 1,579 | +68 | +4.5% | 13,322,400 |
| 2023/07/03 | 1,543 | 1,546 | 1,483 | 1,511 | +11 | +0.7% | 10,827,500 |
| 2023/06/30 | 1,453 | 1,526 | 1,424 | 1,500 | +59 | +4.1% | 18,344,000 |
| 2023/06/29 | 1,600 | 1,610 | 1,390 | 1,441 | -519 | -26.5% | 52,341,400 |
| 2023/06/28 | 1,960 | 1,960 | 1,960 | 1,960 | -500 | -20.3% | 156,300 |
| 2023/06/27 | 2,460 | 2,460 | 2,460 | 2,460 | -700 | -22.2% | 158,400 |
| 2023/06/26 | 2,957 | 3,175 | 2,948 | 3,160 | +188 | +6.3% | 1,553,500 |
| 2023/06/23 | 3,020 | 3,030 | 2,964 | 2,972 | -33 | -1.1% | 811,800 |
| 2023/06/22 | 2,950 | 3,015 | 2,931 | 3,005 | +47 | +1.6% | 883,800 |
301～
350
件表示中 / 4976件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
